A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults

Conditions

• Safety, and Tolerability

Interventions

• COMBINATION_PRODUCT: DHE inhalation powder low dose administered via dry powder inhaler (DPI) device
• COMBINATION_PRODUCT: DHE inhalation powder high dose administered via dry powder inhaler (DPI) device
• DRUG: DHE injected intravenously (1 mg)
• DRUG: DHE 2 mg administered by nasal spray (Migranal®)
• DRUG: Metoclopramide 10mg

Sponsor

Aspeya Switzerland SA